A carregar...
Prostanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities
Pathophysiologic gaps in the actions of currently available treatments for asthma and COPD include neutrophilic inflammation, airway remodeling, and alveolar destruction. All of these processes can be modulated by cyclic adenosine monophosphate-elevating prostaglandins E(2) and I(2) (also known as p...
Na minha lista:
| Publicado no: | Chest |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American College of Chest Physicians
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4631042/ https://ncbi.nlm.nih.gov/pubmed/26204554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.15-1029 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|